Results 71 to 80 of about 2,340 (179)

Summary of Research: Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trials (the ENHANCE Trials). [PDF]

Adv Ther
Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Rickard K, O'Donovan K, Sciurba F.   +6 more
europepmc   +1 more source

Synthesis of the new ring systems indeno[1,2-d]pyrimidinones, indeno[1,2-e]pyrrolo[1,2-a]pyrimidinones and indeno[1,2-e]pyrimido[1,2-a]izoindoles

ARKIVOC, 2005
Márta Palkó, Máté Dervarics, Ferenc Fülöp   +2 more
doaj   +1 more source

Development of Novel Anticancer Pyrazolopyrimidinones Targeting Glioblastoma. [PDF]

ChemMedChem
Byrne K, Bednarz N, McEvoy C, Stephens JC, Curtin JF, Kinsella GK.   +5 more
europepmc   +1 more source

Mutations in the Esx-3 secretion system confer resistance to multiple chemical scaffolds in <i>Mycobacterium tuberculosis</i>. [PDF]

Microbiology (Reading)
O'Malley T, McNeil MB, Dennison D, Ioerger T, Parish T.   +4 more
europepmc   +1 more source

Access to Pyrazolo[1,5-<i>a</i>]pyrimidinone Regioisomers from Acylated Meldrum's Acids. [PDF]

Org Lett
Donzel M, Chorell E.
europepmc   +1 more source

A Case of Immunotherapy Response to BRAF^V600E-Mutant Lung Adenocarcinoma With Initial Resistance to Dabrafenib and Trametinib Combination Therapy. [PDF]

Cancer Rep (Hoboken)
Okayama Y, Tokito T, Shiraishi S, Takaki R, Tsuneyoshi S, Yamada H, Nishiyama M, Sueyasu Y, Hoshino T.   +8 more
europepmc   +1 more source

Ag₂WO₄ nanocatalyst-driven green synthesis of pyrano[2,3-<i>d</i>]pyrimidinones: an integrated experimental, DFT, and cytotoxic investigation. [PDF]

RSC Adv
Perumal S, Perumal S, Muthuraja P, Sasikumar M, Krishna RH, Manisankar P, Subramanian V.   +6 more
europepmc   +1 more source

Prolonged ventricular fibrillation treated with nifekalant in fulminant myocarditis following late-onset coronavirus disease 2019. [PDF]

BMJ Case Rep
Ojima S, Kubozono T, Kawabata T, Kawasoe S, Yamaguchi S, Enokida Y, Mukai S, Kanda D, Ohishi M.   +8 more
europepmc   +1 more source

KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra-Cerebral AVM. [PDF]

Pediatr Dermatol
Zhang D, Kwon JM, Aagaard-Kienitz B, Rebsamen SL, Mc Dermott SE, Arkin LM.   +5 more
europepmc   +1 more source

Design and preparation of a new Ni/Arg@zeolite-Y nano-composite: investigation of its performance as a multi-functional and bio-organic catalyst for the one-pot synthesis of thieno[2,3-<i>d</i>]pyrimidinones. [PDF]

RSC Adv
Kalhor M, Modares Z, Azizkhani V.
europepmc   +1 more source